NCT00318604|Unknown
Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
1 other identifier
94042
Study Type
observational
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredApr 2006
Brief Summary
This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2006
Completed2 days until next milestone
First Posted
Study publicly available on registry
April 27, 2006
CompletedLast Updated
May 12, 2006
Status Verified
April 1, 2006
First QC Date
April 25, 2006
Last Update Submit
May 11, 2006
Conditions
Keywords
plasma circulating DNAhean and neck cancersesophageal cancerlocalized head and neck cancerslocalized esophageal cancer
Eligibility Criteria
Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
You may qualify if:
- Head and neck cancers
- Esophageal cancer
- Undergoing anti-cancer treatments
You may not qualify if:
- No distant metastasis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Head and Neck NeoplasmsEsophageal Neoplasms
Condition Hierarchy (Ancestors)
Neoplasms by SiteNeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal Diseases
Study Officials
- PRINCIPAL INVESTIGATOR
LeJung Wu, MD, DPhil
Far Eastern Memorial Hospital
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 25, 2006
First Posted
April 27, 2006
Last Updated
May 12, 2006
Record last verified: 2006-04